ENVALITH
株式会社海帆 logo

kaihan co.,Ltd.

3133Growth MarketRetail Trade

株式会社海帆 logo
kaihan co.,Ltd.3133

Business

Kaiho Co., Ltd. was founded in 2003 in Nagoya City and is a TSE Growth-listed company whose corporate mission is the "creation of a happy food culture." In its core restaurant business, the company operates 42 directly-managed and franchised stores in total, centered on its "Shinjidai" format, with the Tokai region as its dominant base. Since 2022, the company has added a renewable energy business (solar and hydroelectric power generation) and, from 2024, a medical business centered on an MS (medical service) corporation for beauty clinics that became a subsidiary, transitioning to a three-segment structure. Consolidated net sales for FY2026 (ending March 2026) were ¥3,153 million (up 13.0% year on year). Major customers include general consumers who use izakaya (Japanese-style pubs), electricity purchasers (such as Amazon Data Services Japan LLC), and medical corporations Taibikai and Shueikai.

Business Model

In the food and beverage business, the company combines franchise-operated stores such as "Shinjidai" with directly managed outlets, pursuing profitability through management of ingredient costs and labor expenses. In the renewable energy business, the company aims for stable earnings centered on a long-term power sales agreement with Amazon (through 2045). In the medical business, based on a 10-year consulting services outsourcing agreement with Medical Corporation Daibikai (through 2034), the company provides comprehensive support including advertising, SNS, reservation management, and business management, generating monthly fee income under this structure.

Company Strengths

In May 2021, the company entered into a franchise agreement with Fazz Co., Ltd. to promote the conversion from its existing business format to "Shinjidai" (New Era). As of the end of March 2026, the number of stores had expanded to 20 across the group, and segment sales reached ¥2,461 million. Sales have been maintained even after the business format conversion, up 1.4% year on year, indicating an accumulation of conversion track record.

Under the long-term power purchase agreement (through March 2045) for a Non-FIT low-voltage solar power plant concluded in May 2023 between KR Energy No. 1 LLC and Amazon Data Services Japan LLC, long-term electricity sales revenue is contractually secured. Sales in the renewable energy business expanded 128.2% year on year to ¥194 million.

Based on the consulting service agreement concluded in August 2024 with Medical Corporation Taibikai (10-year term through July 2034), sales in the medical business increased 77.4% year on year to ¥498 million. With support also extended to Medical Corporation Shueikai, the customer base has expanded to multiple corporations.

ENVALITH's Perspective

Net loss attributable to owners of the parent for FY2026 (ending March 2026) expanded roughly sevenfold to ¥5,135 million from ¥737 million in the prior period. The main cause was the recognition of an impairment loss of ¥3,354 million associated with the suspension and reassessment of the Nepal hydropower business, and goodwill balance also fell sharply from ¥1,589 million to ¥232 million. The equity ratio declined from 30.7% to 4.9%, with equity capital remaining at just ¥245 million. The company has posted continuous losses on a non-consolidated basis since FY2019 (ending March 2019) and on a consolidated basis since FY2023 (ending March 2023), and it has disclosed breaches of financial covenants with some financial institutions. Material uncertainty regarding the going concern assumption is the most significant investment risk.

The forecast for the next fiscal period has been left as "undetermined," as reasonable calculation was deemed difficult due to the recognition of goodwill impairment losses at consolidated subsidiaries and the review of the Nepal hydropower business. External factors cited include intensifying global trade friction, geopolitical risk, surging resource prices, yen depreciation, and worsening labor shortages, with no visibility yet on when the food service, renewable energy, and medical businesses will turn profitable. For investors, the absence of an earnings forecast removes a benchmark for valuation, heightening uncertainty around the share price.

Net sales expanded roughly fourfold over four periods, from ¥777 million in FY2022 (ending March 2022) to ¥3,153 million in FY2026 (ending March 2026), while selling, general and administrative expenses surged to ¥3,692 million (from ¥2,456 million in the prior period), substantially exceeding gross profit of ¥2,253 million. Interest expense also swelled 3.5-fold to ¥187 million (from ¥53 million in the prior period), with financing reliant on bonds and borrowings pushing up financial costs. The period-end balance of cash and cash equivalents was extremely thin at ¥208 million, and operating cash flow was negative ¥1,105 million, reflecting a financial structure in which continued business operations remain difficult without external funding.

Growth Strategy

Strengthening the earnings base through three pillars: expansion of the food & beverage franchise, buildup of renewable energy power sales, and expansion of medical business clients

The company will continue converting store formats to "Shinjidai" under the franchise agreement with Fads Inc., maintaining and expanding the group total to 20 stores (as of end-March 2026). It aims to improve the profit margin of existing stores through strengthening human capital, improving quality, service, and cleanliness, and thoroughly managing food cost and labor cost.

KR ENERGY JAPAN LLC and KR Energy No.1 LLC will continue constructing solar power generation facilities and selling electricity, aiming for a gradual contribution to earnings. The Nepal hydropower business (total planned generation capacity of 281.4MW) is currently suspended and under reassessment, and whether the project can be restarted holds the key to medium- to long-term earnings.

Through Kaihan Medical, the company will enhance the precision of advertising and management support provided to medical corporations Daibikai and Shueikai, strengthening support that directly contributes to expanding partners' sales and profits. It will also concurrently consider new revenue models to reduce the risk of dependence on specific business partners.

The company will continue to pursue a combination of fundraising methods, including third-party allotments of new shares, stock acquisition rights, and bond issuances, to secure liquidity on hand. Through regular discussions with financial institutions, it will address responses to financial covenant breaches, aiming to resolve the material uncertainty regarding the going concern assumption.

Last updated: July 19, 2026